Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven C van Dijkman

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 22, 2017
Biomarkers in epilepsy-A modelling perspectiveSven C van Dijkman, Rob A Voskuyl, Elizabeth C de Lange
British Journal of Clinical Pharmacology|August 18, 2017
Pharmacokinetic interactions and dosing rationale for antiepileptic drugs in adults and childrenSven C van Dijkman, Willem M Rauwé, Meindert Danhof, et al.
British Journal of Clinical Pharmacology|May 4, 2018
Futility of current urine salbutamol doping controlJules A A C Heuberger, Sven C van Dijkman, Adam F Cohen
Expert Opinion on Drug Metabolism & Toxicology|July 20, 2016
Pharmacotherapy in pediatric epilepsy: from trial and error to rational drug and dose selection - a long way to goSven C van Dijkman, Ricardo Alvarez-Jimenez, Meindert Danhof, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 6, 2025
Item Response Modeling and Artificial Neural Network for Differentiation of Parkinson's Patients and Subjects Without Evidence of Dopaminergic DeficitLeticia Arrington, Sven C van Dijkman, Elodie L Plan, et al.
British Journal of Clinical Pharmacology|July 18, 2025
Cefuroxime axetil dosing regimens and probability of target attainment in adults and childrenSven C van Dijkman, Praveen Kamble, Jerzy A Kowalski, et al.
Clinical Pharmacology and Therapeutics|June 28, 2017
Individualized Dosing Algorithms and Therapeutic Monitoring for Antiepileptic DrugsSven C van Dijkman, Sebastian G Wicha, Meindert Danhof, et al.
Clinical Pharmacokinetics|July 21, 2018
Authors' Reply to Standing et al.: "Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials"Sven C van Dijkman, Nico C B de Jager, Willem M Rauwé, et al.
British Journal of Clinical Pharmacology|January 14, 2026
An open-label, single-arm, dose-escalating concentration-QT study to investigate the cardiac effects and safety of paroxetine in healthy adultsSven C van Dijkman, Mathieu Félices, Bhaskar Pandurangavittal, et al.
Clinical Pharmacokinetics|April 26, 2018
Correction to: Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical TrialsSven C van Dijkman, Nico C B de Jager, Willem M Rauwé, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 22, 2017
Biomarkers in epilepsy-A modelling perspectiveSven C van Dijkman, Rob A Voskuyl, Elizabeth C de Lange
British Journal of Clinical Pharmacology|August 18, 2017
Pharmacokinetic interactions and dosing rationale for antiepileptic drugs in adults and childrenSven C van Dijkman, Willem M Rauwé, Meindert Danhof, et al.
British Journal of Clinical Pharmacology|May 4, 2018
Futility of current urine salbutamol doping controlJules A A C Heuberger, Sven C van Dijkman, Adam F Cohen
Expert Opinion on Drug Metabolism & Toxicology|July 20, 2016
Pharmacotherapy in pediatric epilepsy: from trial and error to rational drug and dose selection - a long way to goSven C van Dijkman, Ricardo Alvarez-Jimenez, Meindert Danhof, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 6, 2025
Item Response Modeling and Artificial Neural Network for Differentiation of Parkinson's Patients and Subjects Without Evidence of Dopaminergic DeficitLeticia Arrington, Sven C van Dijkman, Elodie L Plan, et al.
British Journal of Clinical Pharmacology|July 18, 2025
Cefuroxime axetil dosing regimens and probability of target attainment in adults and childrenSven C van Dijkman, Praveen Kamble, Jerzy A Kowalski, et al.
Clinical Pharmacology and Therapeutics|June 28, 2017
Individualized Dosing Algorithms and Therapeutic Monitoring for Antiepileptic DrugsSven C van Dijkman, Sebastian G Wicha, Meindert Danhof, et al.
Clinical Pharmacokinetics|July 21, 2018
Authors' Reply to Standing et al.: "Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials"Sven C van Dijkman, Nico C B de Jager, Willem M Rauwé, et al.
British Journal of Clinical Pharmacology|January 14, 2026
An open-label, single-arm, dose-escalating concentration-QT study to investigate the cardiac effects and safety of paroxetine in healthy adultsSven C van Dijkman, Mathieu Félices, Bhaskar Pandurangavittal, et al.
Clinical Pharmacokinetics|April 26, 2018
Correction to: Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical TrialsSven C van Dijkman, Nico C B de Jager, Willem M Rauwé, et al.
Pageof 2